KYTX CIK: 1994702

Kyverna Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY23:
−52.4
FY24:
−114
FY25:
−154
Change from FY23 to FY25
millions USD
FY23:
−8.79
FY24:
−161
FY25:
40.0
Change from FY23 to FY25
millions USD
FY23:
58.1
FY24:
337
FY25:
141
millions USD
FY23:
−3.08
FY24:
62.0
FY25:
27.5
(positive)
Change from FY23 to FY25
millions USD
FY23:
−53.0
FY24:
−116
FY25:
−154

All amounts in millions USD Data source:SEC EDGAR